Introduction
Infertility, observed after 12 months of regular sexual intercourse, is a major health issue with at least 9% of couples requiring medical assistance to conceive a child (Boivin et al., 2007) . It is therefore estimated to concern 72.4 million couples worldwide with 40.5 million currently seeking medical care (Boivin et al., 2007) . In half of these cases, spermatograms identify a reduced sperm quantity or quality, suggesting that a male factor is present, alone, or in conjunction with a female cause, in half of the concerned couples (Thonneau et al., 1991; Poongothai et al., 2009; Krausz, 2011) . The diagnosis of male infertility is often merely descriptive, the etiology of the sperm defect remaining idiopathic in 30 -50% of cases (Krausz, 2011; Tüttelmann et al., 2011b) . One of the reasons for this lack of fundamental understanding is the heterogeneity of causal factors, as male infertility is a typical multifactorial disorder (Brugo-Olmedo et al., 2001) . Genetic factors are however likely to be very frequent as it has been estimated that a genetic origin of male infertility could be found in nearly 1 in 40 men (Tüttelmann et al., 2011a) . Chromosomal aberrations (mainly 47,XXY-Klinefelter syndrome), microdeletions of the Y chromosome and cystic fibrosis transmembrane conductance regulator (CTFR) mutations have been unambiguously demonstrated to be recurrent genetic causes of male infertility (Popli and Stewart, 2007; Vogt et al., 2008; Jungwirth et al., 2012) . Despite this, routine screening for these well-established genetic causes (in principle justified only for patients presenting with certain specific phenotypes) results in a diagnosis in ,5% of all phenotypes (Nieschlag et al., 2010) . We can therefore safely assume that the bulk of the genetic causes of male infertility is still uncharacterized, likely due to the large number of genes involved (Matzuk and Lamb, 2002) and the lack of ambitious studies carried out on large cohorts of affected men.
Over the past years the genetic investigations of severe teratozoospermias has been one of the most productive areas within the topic of male infertility and recurrent mutations have been identified in three specific phenotypes, which are macrozoospermia, globozoospermia and multiple morphological abnormalities of the flagella (MMAF) (Fig. 1) .
Teratozoospermia is defined as a percentage of morphologically normal spermatozoa below the lower reference limit. Cut-off values for normality varied greatly in recent decades from 50% in the first World Health Organization (WHO) classification (WHO, 1980) to 4% in the last version published in 2010 (Ombelet et al., 1995; World Health Organization 2010) . This traditional definition of teratozoospermia is based on the identification of atypical sperm shapes in sperm smears thereby excluding ultrastructural defects invisible under light microscope (Kruger et al., 1986) . Chemes and collaborators proposed to revisit this concept taking into consideration ultrastructural sperm anomalies underlying their functional incompetence. This new approach pushes back the limits of the definition of teratozoospermia beyond the mere description of spermatozoa morphology (Chemes and Rawe, 2003; Chemes and Alvarez Sedo, 2012) . Such examination is however not compatible with the routine semen examination carried out in reproductive clinics. Teratozoospermia represents a heterogeneous group including a wide range of abnormal sperm phenotypes affecting, solely or simultaneously, the head, neck, midpiece and tail. Distinctions should also be made between specific forms with a homogenous monomorphic phenotype shared between several patients and forms with heterogeneous sperm anomalies (non-specific) randomly distributed in each individual and among different patients (Chemes and Rawe, 2003) .
Oligoasthenoteratozoospermia (OAT) is one of the most common phenotypes of male infertility. It is defined by a combination of qualitative and quantitative sperm defects (Jungwirth et al., 2012) . Due to a high phenotypic variability, genetic causes of OAT have not been clearly identified and remain so far largely unknown. Many genetic association studies reported numerous variants associated with OAT, the validity of which remains to be established. Many knockout mice have also been described to present with OAT (Matzuk and Lamb, 2008) . No mutations have however been identified in their human orthologs with the exception of CAMK4 which was mutated in two patients with OAT (Khattri et al., 2012) . A candidate gene approach also allowed the identification of a double amino-substitution in NANOS1, a gene that is apparently not required for spermatogenesis in the mouse (Haraguchi et al., 2003) , in one man with OAT (Kusz-Zamelczyk et al., 2013) . These mutations however, were not formally functionally validated and no further studies confirmed their implication in OAT.
Abnormalities of the sperm flagella always induce asthenozoospermia. They present highly variable morphological defects which can also affect the head and are sometimes associated with oligozoospermia. As such, some patients can be classified as a subgroup of OAT. A mosaic of different flagellar abnormalities is usually observed within the same spermogram including absent, short, bent, angulated or irregular flagella with also a high incidence of head defects. This phenotype has previously been reported as 'short tails' or 'stump tails' (Neugebauer et al., 1990; Baccetti et al., 1993; Stalf et al., 1995; Dávila Garza and Patrizio, 2013) or dysplasia of the fibrous sheath (David et al., 1993; Olmedo et al., 1997 Olmedo et al., , 2000 Chemes et al., 1998; Rawe et al., 2001; Moretti et al., 2011; Ghedir et al., 2014) . As none of the previous terms seem to accurately define this phenotype because these patients' flagella present with a mosaic of ultrastructural flagellar defects as well as of morphological abnormalities including short tails but also, bent, curled, thick and missing flagella we previously proposed to call this heterogeneous group of subjects 'MMAF' for multiple morphological anomalies of the flagella (Ben Khelifa et al., 2014) . We will use here this descriptive definition for this heterogeneous phenotype. These flagellum morphological defects are however unevenly reported or are sometimes only observed in a small fraction of patient's spermatozoa. Some gene defects have been identified which seem to induce such phenotypes including mutations in solute carrier family 26 (SLC26A8) or septin 12 (SEPT12) identified in a subset of patients with asthenozoospermia and teratozoospermia including a bent tail and/or a round head with an abnormal acrosome Lin et al., 2012; Dirami et al., 2013) . These genes were described as being involved in the organization of the septin rings forming the annulus. Other patients have been studied presenting a more severe phenotype with close to 100% abnormalities and mutations in DNAH1, a gene coding for an inner dynein arm protein, identified in 28% of the patients analyzed (Ben Khelifa et al., 2014) .
Other phenotypes can be considered as pure teratozoospermia with 100% abnormal sperm and with a constant uniform pattern of anomalies, such as globozoospermia, large-headed multiflagellar spermatozoa or acephalic spermatozoa. To date, several genes were identified in most of these specific teratozoospermia in humans. The identification and study of these genes shed a much-needed light on the physiopathology Figure 1 Light microscopy analysis of spermatozoa from different types of genetic infertility. Sperm morphology was assessed with Harris-Shorr staining:
nuclei are blue and mitochondria red. (A) Control spermatozoa present a normal-shaped head, a typical short midpiece followed by a long principal piece. (B) A typical macrospermic spermatozoon from a patient with a homozygous aurora kinase C (AURKC) c.144del mutation presents a large head and several flagella. (C) A typical globospermic spermatozoon from a dpy-19-like 2 (DPY19L2) deleted patient presents a round-shaped head and an absence of mitochondria in the midpiece. (D) Spermatozoa from a patient with a homozygous dynein, axonemal, heavy chain 1 (DNAH1) mutation with multiple morphological abnormalities of the flagella (MMAF) phenotype present various defects of the flagellum. Scale bars 10 mm.
Genetic causes of teratozoospermia of teratozoospermia, as a prerequisite to improve the patient management, to provide a basis for the development of therapeutic solutions tailored to the gene defect and to provide the patients with adequate genetic counseling and expected treatment outcome. Moreover, since the investigation of gene function in human is difficult, the elucidation of the function of mutated genes and identification of possible candidate genes in animal models is crucial for the identification of factors affecting male fertility. Numerous animal models, and in particular mutant mouse models related to teratozoospermia, have been extensively described in the literature (for review Yan, 2009; De Boer et al., 2015) . In this review we focus on specific teratozoospermic phenotypes for which a recurrent and reliable genetic cause has been identified in human. We provide an update of the genetic etiology of these phenotypes, summarize their underlying molecular mechanisms and detail the clinical implications arising from these findings.
Methods
A computerized literature search was conducted for all publications in PubMed/Medline until September 2014. We searched using the following MeSH or key word terms: teratozoospermia (402 records) OR globozoospermia (114 records) OR large-headed spermatozoa (35 records) OR macrozoospermia (3 records) OR macrocephalic sperm head syndrome (8 records) OR short tail sperm (187 records) OR stump tail sperm (22 records) OR dysplasia fibrous sheath (39 records) OR primary flagellar abnormalities (22 records) OR primary ciliary dyskinesia (2135 records) OR flagellum biogenesis (260 records) with a possible combination with the keywords genetics, animal models, knockout, diagnosis and ICSI. Any additional relevant articles identified from the bibliography of the initially retrieved articles and reviews were then included (24 records). Only Englishlanguage publications or articles in other languages, but with a sufficiently detailed abstract in English were included. Additionally, we have opted to focus on articles regarding specific teratozoospermia phenotypes for which a gene was formally identified in human in several non-related individuals thereby reducing the risk of erroneous diagnosis. Heterogeneous phenotypes such as OAT (249 records) or pure phenotypes but with no identified genetic cause such as 'decapitated spermatozoa' (46 records) were not included in this review. Last, we did not include studies describing the association between single nucleotide polymorphisms (SNPs) and a particular phenotype (588 records) as we believe that many of these reports may have a low level of evidence. Concerning animal models, we selected a restrictive list of knockout (KO) models among every mutant model described in the literature related to infertility and in particular teratozoospermia (1160 records) (for exhaustive review see Yan, 2009; De Boer et al., 2015) . Only KO mice with a globozoospermia-like phenotype (14 records), mutant mice with inactivated aurora kinase (Aurk)c, Aurkb and dynein axonemal heavy chain 1 (Dnah1) genes (17 records) and mice with central pair microtubule defects leading to flagellar abnormalities (10 records) are presented in this review.
Large headed multiflagellar spermatozoa
Patients with large-headed multiflagellar spermatozoa (MIM 243060), named also macrozoospermia or macrocephalic sperm head syndrome, present with a primary infertility characterized by the presence in the ejaculate of 100% abnormal spermatozoa with an oversized irregular head, abnormal midpiece and acrosome, and multiple flagella (Fig. 1B) . Ultrastructural study of such spermatozoa revealed a 3-fold increase in nuclear volume and on average 3.6 flagella for each sperm head (Escalier, 1983) . This teratozoospermia is also generally associated with a severe oligoasthenozoospermia (Escalier, 1983; Benzacken et al., 2001; Devillard et al., 2002) . This spectacular phenotype has been regularly described in the scientific literature since its initial description 37 years ago (Nistal et al., 1977; German et al., 1981; Escalier, 1983; In't Veld et al., 1997; Pieters et al., 1998; Kahraman et al., 1999; Benzacken et al., 2001; Devillard et al., 2002; Guthauser et al., 2006; Mateu et al., 2006; Perrin et al., 2008; Chelli et al., 2010; Brahem et al., 2012) .
Aneuploidy and abnormal morphology: AURKC is the key
Several studies using Feulgen-stained preparations (German et al., 1981) , spermatocyte C-banding (Pieters et al., 1998) and mainly fluorescence in situ hybridization (FISH) analysis showed a high rate of polyploidy and aneuploidy in spermatozoa from men with macrozoospermia. In these reports, the number of spermatozoa interpreted as haploid varied from 0 to 10.9%, as diploid from 19.8 to 60%, as triploid from 10 to 62.4% and as tetraploid from 5.1 to 36% (Yurov et al., 1996; In't Veld et al., 1997; Weissenberg et al., 1998; Viville et al., 2000; Benzacken et al., 2001; Devillard et al., 2002; Lewis-Jones et al., 2003; Vicari et al., 2003; Guthauser et al., 2006; Mateu et al., 2006; Achard et al., 2007; Perrin et al., 2008; Chelli et al., 2010; Brahem et al., 2012) . Partial forms of this syndrome have been described with various percentages of large-headed spermatozoa. These 'mosaic' forms showed a percentage of euploid spermatozoa roughly correlated with their ratio of normally-sized gametes (Vicari et al., 2003; Achard et al., 2007; Brahem et al., 2012) . Taken together, these observations provide evidence indicating that chromosome nondisjunction and/or cytokinesis defects occurring during the first, the second or both meiotic divisions are consistently associated with large-headed spermatozoa (Escalier et al., 1992; In't Veld et al., 1997; Weissenberg et al., 1998; Benzacken et al., 2001; Devillard et al., 2002) .
A description of familial cases with consanguineous parents was suggestive of a genetic cause with an autosomal recessive inheritance. In 2007, a genome-wide low-density microsatellite analysis led to the identification of a common region of homozygosity in 7 out of 10 North African macrozoospermic patients, located in the terminal region of chromosome 19 long arm. The AURKC gene, localized in the center of this region, appeared as the ideal candidate because it was described as being expressed preferentially in male germ cells and to be involved in chromosomal segregation and cytokinesis (Fig. 2) , two functions that could explain the abnormal sperm morphology and cytogenetic content of large-headed spermatozoa (Dieterich et al., 2007) . Sequencing of the AURKC coding sequence allowed the identification of the same homozygous deletion (c.144delC) in all 14 patients included in the study. This mutation introduces a frameshift resulting in a premature termination of translation and yielding a truncated protein lacking its conserved kinase domain (Dieterich et al., 2007) . It was later demonstrated that the mutated transcript is in fact degraded by the mechanism of nonsense mediated mRNA decay, thus indicating that these patients do not even produce the truncated protein . In another study, using flow cytometry in AURKC-mutated patients, Dieterich et al. (2009) demonstrated that all spermatozoa had a homogenous tetraploid DNA content indicating that patient' germ cells undergo DNA synthesis but remain blocked without completing either of the two meiotic divisions (Fig. 2) . These results were discordant with previous FISH studies, which showed a wide heterogeneity of chromosomal abnormalities. The authors indicated that this difference is mainly due to the limits of the FISH technique and that in these abnormal gametes the superposition of FISH signals led to a great underestimate of the number of chromosomes/chromatids (Dieterich et al., 2009) . Surprisingly, in spite of this meiotic arrest, spermiogenesis is not blocked suggesting that meiotic checkpoint controls are abolished or inefficient in these patients. Most macrozoospermic patients however present a severely reduced sperm count concordant with the mathematical reduction in sperm number due to the absence of cell division and a partial effect of the meiotic checkpoints .
AURKC function in meiotic cells: between specificities and complementarities AURKC belongs to the Aurora kinases family, which are highly evolutionary conserved serine/threonine kinases playing a key role in the control of mitosis and meiosis. In Mammals, aurora kinases also comprise two other family members, aurora kinase (AURKA) and aurora kinase B (AURKB). The three kinases share a high sequence homology in their central kinase domain and have a common ortholog in Drosophila and yeast (Sunkel and Glover, 1988; Chan and Botstein, 1993; Glover et al., 1995) . Despite their similarities, the three Aurora kinases have distinct localizations and functions. Divergences in the N-terminal domains of these proteins confer specific protein -protein interactions abilities (Carmena and Earnshaw, 2003) . AURKA and B play distinct roles during mitosis: AURKA controls centrosome maturation, bipolar assembly and chromosome separation while AURKB regulates chromosome segregation, kinetochore -microtubule interaction and cytokinesis (Goldenson and Crispino, 2014) . Much less is known about AURKC which was described more recently. AURKC recently evolved from AURKB after gene duplication (Brown et al., 2004) , and therefore shares a high degree of homology with AURKB (73%). AURKC is expressed predominantly in testis, in particular in dividing spermatocytes, and in oocytes whereas AURKA and B are expressed ubiquitously (Bernard et al., 1998; Tseng et al., 1998; Assou et al., 2006; Tang et al., 2006; Yang et al., 2010) . AURKC has also been described as highly expressed in early human preimplantation embryos (Avo Santos et al., 2011) . There are several lines of evidence that strongly suggest that AURKC can function in place of AURKB in meiotic cells. First, AURKC function can overlap with AURKB as evidenced by the fact that AURKC could rescue AURKB-depleted somatic cells (Li et al., 2004; Sasai et al., 2004; Yan et al., 2005) . This was also supported by the fact Genetic causes of teratozoospermia that AURKC is sufficient to drive mitotic progression during early embryonic divisions in preimplantation mouse embryos lacking AURKB (Fernández-Miranda et al., 2011) . The study of KO mice also demonstrated a respective functional compensation of both kinases during meiosis and embryonic development (Fernández-Miranda et al., 2011; Schindler et al., 2012) . Moreover, it has been reported that AURKC, like AURKB, is a component of the chromosomal passenger complex (CPC) with a similar localization and interaction with other subunits such as inner centromere protein antigens 135/155 kDa (INCENP), survivin (BIRC5) and Borealin (CDCA8) (Chen et al., 2005; Vader et al., 2008) . CPC is a pivotal regulator of mitotic events including chromosome segregation and cytokinesis (Vagnarelli and Earnshaw, 2004) . During chromosome alignment, CPC corrects chromosome-microtubule attachment errors generating temporarily unattached kinetochores, a condition sensed by the spindle assembly checkpoint (SAC) (Vader et al., 2008; Carmena et al., 2012; van der Waal et al., 2012; van der Horst and Lens, 2014) . The SAC represents one of the main mechanisms of cell division control ensuring fidelity in chromosome segregation. It verifies whether prerequisites for chromosome segregation have been met and thereby determines whether to execute or to delay chromosome segregation (Musacchio and Hardwick, 2002; Zhou et al., 2002) . In addition it has been demonstrated that Aurora kinases could contribute to recruiting different mitotic checkpoint components such as BUB1 mitotic checkpoint serine/threonine kinase (BUB1) to the kinetochore (Becker et al., 2010; van der Waal et al., 2012) . Impairment of CPC functions results in chromosome segregation defects, altered SAC and cytokinesis failure. Such perturbations in mitosis can lead to the production of aneuploid/polyploid cells, which then often become malignant. By comparison, abnormalities in CPC during meiosis are expected to lead to the production of chromosomally unbalanced gametes (Sharif et al., 2010; Yang et al., 2010; van der Waal et al., 2012; van der Horst and Lens, 2014) .
Many experimental studies tried to address AURKB and AURKC specific functions during meiosis. They have so far been largely hampered by the difficulty to selectively inhibit one of the two kinases (Schindler et al., 2012; Balboula and Schindler, 2014) . Only one study supports a preponderant role of AURKB in mouse spermatogenesis based on the study of AURKB transgenic mice, which are shown to be subfertile due to abnormal spermatocytes, increased testicular apoptosis and spermatogenic arrest. The authors however acknowledged that the function of AURKC might also be altered in their AURKB transgenic mutants (Kimmins et al., 2007) . KO strategies did not prove more useful because homozygous Aurkc KO mice do not perfectly mimic the typical human macrozoospermia phenotype. Unlike infertile AURKC-mutated men, KO Aurkc male mice are fertile but with reduced litter size. They have normal testis weight and sperm count but do produce abnormal spermatozoa. Sperm abnormalities include abnormal chromatin condensation, acrosome loss and blunted heads (Kimmins et al., 2007) . It is possible that the milder phenotype observed in mouse compared with human may be due to a greater overlap of AURKB and C functions in mouse than in human spermatogenesis but this remains to be demonstrated.
The function of AURKC has been extensively studied in oocytes. In female mice, the overexpression of a dominant negative allele inhibiting the AURKC activity (AURKC-DN) in oocytes was shown to cause cytokinesis failure in meiosis I resulting in the production of large polyploid oocytes, a pattern similar to that observed in AURKC-deficient human spermatozoa (Yang et al., 2010) . These results are however questionable as AURKB might also be down-regulated in this mouse model (Schindler et al., 2012) . Mice oocytes express both AURKB and C and this double expression might provide a backup ensuring the maintaining of critical functions (i.e. SAC and cytokinesis) in a transcriptionally quiescent cell (Schindler et al., 2012) . Aurkc KO female mice however are subfertile with fewer pups per litter compared with wild type (5.5 versus 7.5 pups, on average per liter), and furthermore their oocytes show a higher incidence of chromosome misalignment and often arrest at meiosis I or later on at the 1-cell stage (Schindler et al., 2012) . Balboula and Schindler (2014) , using a specific catalytically inactive Aurkc mutant (AURKC-LA), show that most AURKC-LA oocytes arrest at metaphase I suggesting that AURKC-CPC is not the sole CPC complex that regulates the SAC in female meiosis. A small percentage of oocytes proceeded through meiosis and induced cytokinesis normally but were aneuploid, indicating that AURKC-CPC is the critical CPC complex necessary to correct improper chromosome-microtubule attachments during meiosis, a central role for preventing aneuploidy (Balboula and Schindler, 2014) . These data indicate that the absence of AURKC is compatible with reproduction but might have an impact during meiosis and/or embryonic development. In human the absence of AURKC is compatible with female reproduction as women with homozygous AURKC mutations were shown to be fertile (Dieterich et al., 2009) . Women with homozygous AURKC mutations could however be subfertile and present an increased risk of miscarriages in relation to the production of aneuploid oocytes. Further studies on the fertility of women with homozygous AURKC mutations should be carried out to conclude on this point.
Lastly, AURKC is expressed at a very low level in other somatic cells types such as brain glial cells, lung, placenta (Yan et al., 2005; Fernández-Miranda et al., 2011) or the pineal gland where it has been implicated in circadian clock function in the rat (Price et al., 2009) . Apart from infertility, homozygous AURKC-mutated patients display no other clinical features suggesting that AURKC is dispensable in somatic cells (Dieterich et al., 2007 (Dieterich et al., , 2009 . AURKC is also aberrantly expressed in some cancer cells but its contribution to oncogenesis is not well explored and understood (Khan et al., 2011; Tsou et al., 2011; Zekri et al., 2012; Goldenson and Crispino, 2014) .
AURKC mutations: the c.144delC reigns supreme
The genotype of macrozoospermic patients described in the literature is summarized in (Table I ). The c.144delC deletion accounts for 85% of the mutated alleles . Other mutations have been identified: p.C229Y, a novel missense mutation in exon 6 and c.144delC (Dieterich et al., 2009) , p.Y248*, a new recurrent non-sense mutation was found in 10 unrelated individuals of European and North African origin and c436-2A.G, leading to a shortened transcript devoid of exon 5 . Overall, and excluding the study of Eloualid (2014) based on an unselected population of infertile men, a positive AURKC mutation diagnosis is found in between 50.8 and 100% of analyzed macrozoospermic patients (Table I) .
Nearly all positive mutated AURKC patients have a typical phenotype, with close to 100% large-head spermatozoa, whereas negative patients have a lower percentage of large-headed spermatozoa (,75%) (Table II) (Dieterich et al., 2009) . Positive hits are strongly correlated with the percentage of large-headed spermatozoa in the ejaculate (Table II) 
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Genetic causes of teratozoospermia mutation was generally found in patients with ,70% of macrocephalic spermatozoa (Dieterich et al., 2009; Ben Khelifa et al., 2011 El Kerch et al., 2011; Eloualid et al., 2014) . Furthermore, although the large majority of men with macrozoospermia present a reduced sperm count, men with extreme oligozoospermia (,0.5 M/ml) were usually not carriers of AURKC mutations. To date Aurora kinase C remains the only gene where mutations were found in patients with a large-headed spermatozoa phenotype. The sequencing of AURKC exons 3 and 6 to search for the two recurrent mutations is appropriate as a first-line genetics test in all patients presenting with large-headed spermatozoa. The sequencing of the remaining exons should be discussed in light of the values of semen parameters. In fact, a sperm concentration .1 million, a percentage of large-head spermatozoa beyond 70% and/or a low percentage of normal spermatozoa (,1%) are in favor of a positive outcomes (Table II) . Others parameters could be taken into account like the presence of multiple flagella. As an example, Molinari et al. (2013) reported a case of sperm macrocephaly syndrome with 95% of large-headed spermatozoa but without tail abnormalities. AURKC gene sequencing did not reveal any mutations in the patient, suggesting that other genes may be involved in determining this atypical syndrome.
The c.144delC mutation accounts for almost all identified AURKC mutations, in particular in a Magrebian population where the prevalence of this mutation at a heterozygous state is estimated to be of 1 in 50 (Dieterich et al., 2009; Eloualid et al., 2014) . Surprisingly, it makes AURKC gene alterations the most frequent defect in infertile Magrebian men before Klinefelter syndrome and Y-microdeletions (Ounis et al., 2015) . It is difficult to precisely calculate the p.Y248* prevalence in North African individuals because the c.144delC is often the only mutation studied (Dieterich et al., 2009; El Kerch et al., 2011; Eloualid et al., 2014) . No reliable data are currently available for European individuals due to a small number of studied patients. However, the recently identified non-sense mutation p.Y248* appears to be the main mutation in individuals of European origin . Both recurrent mutations c.144delC and p.Y248* are founding mutations and ancestral haplotypes were used to compute the age of the two AURKC mutations. It was estimated that c.144delC occurred between 1350 and 1750 AD and p.Y248* between 675 and 1075 AD. The fact that p.Y248* predates c.144delC is confirmed by the observed wider geographical distribution of p.Y248* . It remains surprising that mutations with a negative effect on reproduction should reach such a high prevalence. A possible explanation lies in the assumption that the heterozygous carriers of AURKC mutations may have a selective advantage (Dieterich et al., 2007 (Dieterich et al., , 2009 Ben Khelifa et al., 2012; Ounis et al., 2015) . No clear demonstration of this putative selective advantage has yet been provided and several hypotheses have been advanced. We previously described that AURKC was involved in the SAC. Men with AURKC heterozygous mutations could therefore have a more relaxed meiotic checkpoint permitting a faster meiosis turnover leading to an increased sperm production . The produced gametes would however be expected to present a higher rate of aneuploidies likely to induce a high rate of spontaneous abortions. This hypothesis is supported by several observations of multiple miscarriages or perinatal deaths in the siblings or parents of macrozoospermic patients (Benzacken et al., 2001; Achard et al., 2007; Ounis et al., 2015) .
Curiously, only four different AURKC mutations have been reported so far, and all are involved in the complete form of the phenotype. Ben propose that some mutations could affect only some functions of the AURKC protein: the microtubule -kinetochore attachment and/or cytokinesis, without altering AURKC SAC function. The severity of the defects may depend on the level of kinase inhibition; some functions of the CPC are already disturbed when the complex is only partially inhibited (e.g. correction of microtubule -kinetochore attachment), while others (e.g. its function in the SAC) may require complete inhibition (van der Horst and Lens, 2014) . This would therefore lead to severe quantitative defects, and what could be considered as 'milder' AURKC mutations could be found in azoospermic rather than in macrozoospermic patients. This hypothesis has however not been confirmed yet.
AURKC mutational status and patient management
Although assisted reproductive technologies (ART) have revolutionized the treatment of infertile patients with severe oligoasthenoteratozoospermia, they are inefficient for patients presenting large-headed This study is based on unselected population of 326 idiopathic infertile patients with various sperm parameters and phenotypes. The proportion of patients with macrozoospermia is not available.
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The study included 14 patients previously described in Dieterich et al. (2007) .
£
The study included 41 patients previously described in Dieterich et al. (2009) and 2 patients previously described in Ben . (1) Patient was compound heterozygote carrying the c.144delC and p.C229Y mutations. One patient was compound heterozygote carrying the c.144delC and p.C229Y mutations, two were compound heterozygotes carrying the c.144delC and c.436-2A.G mutations and two were compound heterozygotes carrying the c.144delC and p.Y248* mutations. spermatozoa due to the high frequency of sperm chromosomal abnormalities (Perrin et al., 2008) . Management of patients diagnosed with macrozoospermia should begin with AURKC diagnosis. ICSI will then be formally contraindicated for all homozygous mutated patients who can have recourse to donor sperm or adoption . Careful selection of 'normal-looking spermatozoa' by motile sperm organelle morphology examination (MSOME) has previously been evaluated in several AURKC c.144delC deleted patients. FISH analyses performed on all selected spermatozoa showed that all were aneuploid, confirming that ICSI should not be attempted for AURKC-mutated patients even after a very thorough morphological selection (Chelli et al., 2010) . The prognosis is not as categorically unfavorable for patients not carrying AURKC mutations or with a partial/atypical phenotype. Although low, the chances of pregnancy are not negligible (Kahraman et al., 1999; Achard et al., 2007) . For these men, sperm FISH should be carried out to assess the rate of euploid sperm and evaluate the probability of success. PGD can be proposed for those with an intermediate rate of aneuploid sperm (Kahraman et al., 2004; Dieterich et al., 2009) . Careful scrutiny of the pregnancy and of the perinatal period is however recommended in case of success (Achard et al., 2007) .
Globozoospermia
First described in human in 1971, globozoospermia (MIM 613958) is a rare (incidence 0.1%) and severe form of teratozoospermia characterized by the presence in the ejaculate of a large majority of round spermatozoa lacking the acrosome (Fig. 1C) (Sen et al., 1971; Holstein et al., 1973; Dam et al., 2007a) . Globozoospermic sperm are unable to adhere and penetrate the zona pellucida, causing primary infertility (Dam et al., 2007a) . The initial phenotype was divided into two subtypes: the globozoospermia type I characterized by the complete lack of acrosome and acrosomal enzymes and the globozoospermia type II characterized by a round-headed phenotype due to a residual cytoplasmic droplet surrounding the sperm head and acrosome (Anton-Lamprecht et al., 1976; Singh, 1992) . However, this nomenclature is confusing and was subsequently often misemployed in the literature referring to patients with a homogeneous phenotype with 100% round-headed sperm (type I) or patients with a mosaic of normal and round-headed sperm (type II). The terms 'total' or 'partial' globozoospermia have been proposed and should be preferred to report the homogeneity of the 'original' type I phenotype (Lerer-Goldshtein et al., 2010; Dam et al., 2011) while the rarer, type II phenotype, should be referred as pseudo-globozoospermia.
Globozoospermia and experimental models: a relevant strategy?
Several familial cases of globozoospermia suggested a genetic contribution to this disorder (Kullander and Rausing, 1975; Flö rke-Gerloff et al., 1984; Dale et al., 1994; Kilani et al., 2004; Dirican et al., 2008 n.a n.a n.a n.a Ounis et al. (2015) Deleterious mutations (11) 7.51 (0.5-30.5) 99.5 (95 -100) + n.a No mutation (3) 13 (0. Genetic causes of teratozoospermia of KO mice with a globozoospermia-like phenotype lacking different genes (Table III) . Almost all these genes are ubiquitously expressed and therefore do not appear as good candidates for the human globozoospermia phenotype, which only causes primary infertility. These genes encode endoplasmic reticulum proteins such as heat shock protein 90 kDa beta 1 (Hsp90b1) and glucosidase, beta (bile acid) 2 (Gba2) or vesicle trafficking-related proteins such as casein kinase 2, alpha prime polypeptide (Csnk2a2), ArfGAP with FG repeats 1 (AGFG1 or Hrb), golgi-associated PDZ and coiled-coil motif containing (Gopc), protein interacting with PRKCA 1 (Pick1), TATA element modulatory factor 1 (Tmf1), vacuolar protein sorting 54 (Vps54), small ArfGAP 2 (Smap2) and autophagy related 7 (Atg7). All regulate proacrosomal vesicle transport from the Golgi to the acrosome (Table III and Fig. 3 ). These proteins are implicated in a common pathway and contribute to acrosome biogenesis and sperm head organization (Fig. 3) . Only zona pellucida binding protein (Zpbp or Zpbp1) and sperm acrosome associated 1 (Spaca1) have an expression restricted to the testis (Lin et al., 2007; Fujihara et al., 2012) . Zpbp and Spaca1 are integral acrosomal proteins but display different functions (Lin et al., 2007; Fujihara et al., 2012) . Zpbp is localized in the acrosomal matrix and is involved in the binding and penetration of the sperm into the zona pellucida (Yatsenko et al., 2012) while Spaca1 is a transmembrane protein located in the inner acrosomal membrane of spermatids and mature spermatozoa (Fig. 3) and plays an unsolved role in acrosomal morphogenesis and in sperm-egg binding and fusion (Hao et al., 2002; Fujihara et al., 2012) . None of these mouse models perfectly mirrors the round-shaped acrosomeless spermatozoa observed in human globozoospermia. To date, .50 genetically modified mice reported in the Mouse Genome Informatics database (http://www. informatics.jax.org) contain in their phenotypic description a term related to globozoospermia. This is not surprising in view of the complexity and the multitude of proteins involved in acrosome biogenesis (Alvarez Sedó et al., 2012) . In spite of this large list of mouse candidate genes, only a few mutations have been identified in their human orthologs. Heterozygous missense and splicing mutations in ZPBP were described in patients presenting with abnormal sperm head morphology, but their involvement in the disease has not been clearly demonstrated (Yatsenko et al., 2012) . Similarly, a homozygous missense mutation (G198A) in exon 13 of the PICK1 gene was identified in a Chinese family (Liu et al., 2010) . Again, the report of the identification of a relatively mild mutation without any functional validation in a single familial case remains somewhat unconvincing.
DPY19L2 mutational spectrum: toward a diagnostic strategy
Gene candidate approaches, even with strong animal model data, are often unsuccessful (Pirrello et al., 2005; Christensen et al., 2006) . Homozygosity mapping using genome-wide scan analysis of a consanguineous Ashkenazi Jewish family with three globozoospermic brothers identified a homozygous mutation (c.848G.A) in SPATA16 (spermatogenesisassociated protein 16, previously named NYD-SP12) (Dam et al., 2007b) . The SPATA16 protein localizes to the Golgi apparatus and to the proacrosomal vesicles which fuse to form the acrosome during spermiogenesis (Lu et al., 2006; Dam et al., 2007b) . SPATA16, is highly expressed in human testis and contains a conserved tetratricopeptide repeat (TPR) domain (Xu et al., 2003) which may interact with the GOPC and HRB proteins (Dam et al., 2007b) . No mutation was subsequently found in 30 other patients with globozoospermia originating from Europe or North Africa (Dam et al., 2007b) , suggesting that SPATA16 is not the main cause of globozoospermia, which is likely genetically heterogeneous. Only recently was a new SPATA16 mutation identified in single man from a large cohort of patients with globozoospermia (Karaca et al., 2014) . In 2011, from a cohort of 20 Tunisian patients with 100% globozoospermic sperm, SNP-based genetic linkage analysis identified a common region of homozygosity in 12q14.2 including the dpy-19-like 2 (DPY19L2) gene strongly expressed in testis. A 200-kb homozygous deletion of the DPY19L2 gene was found in 15 of the 20 patients analyzed . This deletion was also identified in a second study published simultaneously in 19% (4 out of 21) of the recruited globozoospermic patients (Koscinski et al., 2011) . Although the deletion frequency is very disparate, both studies conclude that the DPY19L2 deletion is the main cause of globozoospermia. Subsequently, three large studies confirmed the high prevalence of DPY19L2 gene alterations, ranging from 60 to 83.3% of analyzed patients in cohorts of globozoospermic patients from different geographic regions and with different ethnic backgrounds (Table IV) Elinati et al., 2012; Zhu et al., 2013) . A further two publications further strengthen this conclusion, reporting the presence of homozygous DPY19L2 deletion in patients from Macedonia and Algeria (Noveski et al., 2013; Ounis et al., 2015) . Homozygous deletions represent 26.7 to 73.3% of the reported DPY19L2 mutations in the three largest studies (Table IV) Elinati et al., 2012; Zhu et al., 2013) . This heterogeneous deletion rate could be explained by a possible founder effect in some studies with a geographic-based recruitment accentuating the deletion prevalence Coutton et al., 2012; Elinati et al., 2012) . In addition, inclusion parameters are different and DPY19L2 mutations are mainly identified in type I globozoospermia with a typical morphology and a high percentage of affected spermatozoa (Table V) and the inclusion of subjects with a low level of round-headed spermatozoa might in some cases decrease diagnosis efficiency. The genotype-phenotype correlation is however not perfect, indicating that (i) some phenotypic variation exists even within DPY19L2 deleted subjects and (ii) other gene defects likely induce a pure globozoospermia phenotype (Table V) . To enable a better genotype/phenotype correlation great care should be taken to respect the international recommendation for the examination of human semen to standardize the results and avoid protocol variations between the different laboratories (World Health Organization 2010).
Homozygous and compound heterozygous point mutations further broaden the spectrum of DPY19L2-dependent globozoospermia (Table IV) . DPY19L2 point mutations can be either missense mutations localized mainly in the central part of the DPY19L2 protein or nonsense/frameshift/splice-site mutations resulting in truncated proteins Elinati et al., 2012; Zhu et al., 2013) . Small deletions were also reported (Table IV) indicating that exon deletions are part of the mutational spectrum of the DPY19L2 gene (Zhu et al., 2013) . A recurrent missense mutation in exon 8, p.Arg290His, was identified in several unrelated patients. This mutation changes a highly conserved arginine into a histidine and is predicted to be deleterious by multiple prediction tools Elinati et al., 2012; Zhu et al., 2013) . Moreover, a recent study demonstrates that DPY-19, the DPY19L2 ortholog in Caenorhabditis elegans, encodes a C-mannosyltransferase which is able to glycosylate several target proteins using the lipid-linked glycoside dolichol-phosphate-mannose (Dol-P-Man) as the donor substrate (Buettner et al., 2013) . Interestingly, the amino acid corresponding to the Arg290 in C. elegans has been predicted to be involved in the binding of the Dol-P moiety of the substrate (Buettner et al., 2013) . These data suggest that the arginine at position 290 could play a key role in DPY19L2 function. The effect of this potential glycosylation remains to be elucidated. On the whole, the fact that most reported missense mutations occur between exon 8 and 11 could indicate that this central domain of DPY19L2 may support some critical functions. Overall, the deletion of the totality of the DPY19L2 gene represents about 81% of the pathological alleles (Table IV) . Different approaches have been described to effectively detect these DPY19L2 deletions. First, a long-range PCR combined with exon-specific amplification is the most widely used strategy to detect both homozygous and heterozygous deletions (Table IV) Koscinski et al., 2011; Elinati et al., 2012; Noveski et al., 2013; Zhu et al., 2013) . This cost effective strategy allows delineating with a good accuracy the breakpoints of the genomic deletion although this information is not, strictly speaking, useful for the diagnosis and clinically relevant. A strong shortcoming of this technique is that it does not detect the deletions with breakpoints falling outside the region covered by the deletion-specific primers therefore presenting a high risk of false-negative results Zhu et al., 2013) . An alternative strategy is the use of a multiplex ligation-dependent probe amplification (MLPA) approach to determine the number of DPY19L2 alleles for each patient, and independently of the localization of the breakpoint . Drawbacks of MLPA are the relatively higher cost compared with PCR approaches and the required experience for the design of the MLPA specific probes to avoid cross-hybridization with DPY19L2 pseudogenes (Zhu et al., 2013) . Considering these points, we recommend the research of homozygous and heterozygous DPY19L2 deletions as the first-line genetic analysis in globozoospermic by long-range PCR or MLPA Elinati et al., 2012; Zhu et al., 2013) . Alternatively a quantitative PCR protocol could be used (Chianese et al., 2015) . This approach does not rely on breakpoint localization and new robust methods are becoming available which may provide a cheap and fast diagnosis allowing the detection of all recombined alleles. In almost all cases of globozoospermic patients with a heterozygous deletion, an additional point mutation in the non-deleted allele was secondly identified Elinati et al., 2012; Zhu et al., 2013) . This strongly encourages researching such a point mutation in globozoospermic patients heterozygous for the genomic deletion . In the absence of a deletion (heterozygous or homozygous) the full 22 exon DPY19L2 sequencing might not be systematically realized as a routine analysis. Similarly, the very low rate of mutations found in others genes, such as SPATA16 or PICK1, questions the clinical relevance of molecular investigations of such genes . A 'hotspots' restrictive strategy based on the sequencing of the DPY19L2 exons 8-11, in which most of the point mutations were identified, could also be envisaged. The genetic diagnosis of globozoospermia does not yet provide any clear prognostic or therapeutic indications. Nonetheless, a molecular diagnosis remains useful to provide adequate genetic counseling and to better understand the physiopathology of globozoospermia, which might help to identify novel therapeutic solutions.
DPY19L2 functions: new insights on the physiopathology of globozoospermia DPY19L2 belongs to a new family of transmembrane proteins of the nuclear envelope including, in Mammals, fours homologous proteins: DPY19L1 to DPY19L4. Initially, inactivation of DPY-19, the only DPY19L ortholog in C. elegans, was shown to induce a shorter (dumpy) than wild-type phenotype (Brenner, 1974) . DPY-19 has 10 predicted transmembrane domains and was involved in Q neuroblast polarization during early development (Honigberg and Kenyon, 2000) . The four human homologues have 9 -11 predicted transmembrane domains, suggesting a similar protein structure to DPY-19 (Carson et al., 2006) . Moreover, human DPY19L proteins share a high level of sequence identity with DPY-19, consistent with a conservation of the ancestral protein function (Buettner et al., 2013) . Functions of human DPY19L proteins are still poorly understood and in particular for Figure 3 Known proteins involved in acrosome biogenesis whose functional absence leads to globozoospermia or globlozoospermia-like phenotypes in mouse. Acrosome biogenesis includes several steps including protein processing within the reticulum, vesicle trafficking from the Golgi apparatus, vesicle fusion, interaction of the inner acrosomal membrane (IAMb) with the acroplaxome (Apx), interaction of the acroplaxome with the outer and inner nuclear membranes (ONM and INM) of the nuclear envelope and maintaining integrity of the acrosomal matrix. Numerous proteins are involved in these different steps and their absence leads to defective acrosome biogenesis and globozoospermia or globozoospermia-like phenotypes. Only the absence of sperm acrosome associated 1 (Spaca1) and Dpy19l2 leads to the disappearance of the nuclear dense lamina (NDL). Genes abbreviations are as follows: heat shock protein 90 kDa beta 1 (Hsp90b1); glucosidase, beta (bile acid) 2 (Gba2); protein interacting with PRKCA 1 (Pick1); golgi-associated PDZ and coiled-coil motif containing (Gopc); casein kinase 2, alpha prime polypeptide (Csnk2a2); autophagy related 7 (Atg7); small ArfGAP 2 (Smap2); TATA element modulatory factor 1; (Tmf1 or ARA160); zona pellucida binding protein (Zpbp or Zpbp1); vacuolar protein sorting 54 (Vps54); ArfGAP with FG repeats 1 (Hrb), sperm acrosome associated 1 (Spaca1 
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Genetic causes of teratozoospermia DPY19L4 for which nothing is known. It has been demonstrated that down-regulation of Dpy19l1 and Dpy19l3 during neurogenesis of mouse embryos leads to strong neuron migration anomalies (Watanabe et al., 2011) . DPY19L3 has also been associated with bipolar disorder (Smith et al., 2009) . These results strengthen the possibility of a conserved function of the different DPY19L proteins. Interestingly, apart from DPY19L2, which presents a predominant expression in the testis, DPY19L proteins show a relatively ubiquitous pattern of expression (Carson et al., 2006) . After its identification as the main gene involved in globozoospermia, study of Dpy19l2 KO mice showed that homozygous animals faithfully reproduced the human phenotype with a complete male infertility, 100% of acrosomeless round-headed spermatozoa and manchette abnormalities (Table III) . Study of this model led to the conclusion that DPY19L2 is a transmembrane protein located in the inner nuclear membrane (Fig. 3) and that it is necessary to anchor the acrosome to the nucleus. In the absence of Dpy19l2 the forming acrosome slowly separates from the nucleus before being removed from the sperm with the cytoplasm (Pierre et al., 2012) . In addition to its structural function during acrosome biogenesis, the C-mannosyltransferase function of the ancestral protein DPY-19 has raised the hypothesis that DPY19L2 may have a function in glycosylation of sperm proteins (Buettner et al. The study included 20 patients previously described in Harbuz et al. (2011) .
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The study included 21 patients previously described in Koscinski et al. (2011) . n.a n.a n.a n.a No mutation (18) n.a n.a n.a n.a Zhu et al. (2013) Deleterious mutations (9) 46.7 (0.8-90) 183.6 (n.a) n.a 100 (100) No mutation (5) 20 (14-25) 60 (n.a) n.a 100 (100) Noveski et al. (2013) Deleterious mutations (2) n.a n.a n.a 100 (100) No mutation (0) Ounis et al. (2015) Deleterious mutations (5) 64.6 (16-171) n.a 100 (5) 99 (95 -100) No mutation (0) Values are expressed as the mean with the lower and the higher values between brackets if available. n.a: not available; n: number of patients; spz: sperm cells; $ Indicate the number of patients with a deleterious mutations including all types of reported mutations in DPY19L2 (homozygous deletions, point mutations, compound heterozygotes) and the number of patients with no bi-allelic mutation identified. ? Indicated the total number and percentage of patients normozoospermic with a sperm concentration upper to the 5th centiles of World Health Organization 2010 values (15 × 10 6 /ml (CI 12 -16)). 2013). Several potential partner proteins have been proposed to interact with DPY19L2 during spermiogenesis, in particular the SUN proteins belonging to the LINC (linker of nucleoskeleton and cytoskeleton) complexes in association with KASH proteins (Pierre et al., 2012) . SUN proteins appeared as the best candidate due to their abundance during spermiogenesis and their role in nuclear shaping during sperm head formation (Göb et al., 2010; Frohnert et al., 2011) . This hypothesis has however not been confirmed and the molecular partners of DPY19L2 remain to be characterized (Yassine et al., 2015b) . Comparative testicular transcriptome studies of wild type and globozoospermic Dpy19l2 KO mice were also realized to attempt to identify Dpy19l2 molecular partners but no conclusive result was obtained (Karaouzène et al., 2013) .
DPY19L2, low copy repeats and copy number variations: from evolution to mutations
Copy number variations (CNV) refer to gains by duplication or losses by deletion of genetic material greater than 1 kb. They can be pathogenic and cause Mendelian traits or be associated with complex diseases but can also represent benign polymorphic variants. CNVs and in particular gene duplications are involved as a predominant mechanism driving gene and genome evolution (reviewed in Zhang et al., 2009) . Such a mechanism was involved in the DPY19L gene family evolution throughout the vertebrate lineage. The DPY19L family genes, encompassing four genes (DPY19L1, 2, 3 and 4) and six pseudogenes, derived from a common ancestor homologous to the C. elegans dpy-19 gene owing to multiple gene duplications and pseudogenizations throughout evolution (Carson et al., 2006) . It is estimated that the duplication that generated DPY19L2 arose between 173 and 360 million years ago prior to mammalian divergence.
Recurrent CNVs arise mostly by homologous recombination between repetitive DNA sequences. This process is called non-allelic homologous recombination (NAHR) and is well-known in human diseases to be responsible for many recurrent genomic syndromes (Stankiewicz and Lupski, 2010) . The DPY19L2 locus is conducive to recurrent deletions and duplications by NAHR due to the presence of two homologous 28-kb low copy repeats (LCRs) located on each side of the gene Koscinski et al., 2011) . Such a recombination during the meiosis will result in the production of recombinant gametes having either a duplication or a deletion of the DPY19L2 locus. Sequencing analysis of the NAHR breakpoints at the DPY19L2 locus demonstrated that the recombination events occurred preferentially in the vicinity of a 13 nucleotide recognition motif for the PRDM9 protein localized in the center of the 28-kb LCRs . PRDM9, a zinc finger protein that binds to DNA sequences, is a major transregulator of meiotic recombination hotspots facilitating double strand breaks, a prerequisite for NAHR (Baudat et al., 2010; Myers et al., 2010; Parvanov et al., 2010 ). An additional putative recombination hotspot within the 28-kb LCRs might constitute a second, less frequent recombination site (Elinati et al., 2012) .
The NAHR mechanism favors deletions over duplications because the inter-chromatid and inter-chromosome NAHRs create a deleted and a duplicated recombined allele, while intra-chromatid events only generate deletions . More gametes carrying a deletion are thus expected to be produced de novo and this was verified for several NAHR hotspots (Turner et al., 2008) and in particular for the DPY19L2 locus . This is paradoxical regarding the overrepresentation of the duplicated DPY19L2 allele in the general population. In fact, the frequency of the DPY19L2 duplication and heterozygous deletion in the general population is estimated to be 1/85 and 1/290, respectively. This can be explained by the loss of deleted alleles occurring during selection against sterile, homozygous deleted men, whereas duplications carriers are not subjected to selection. Also, heterozygous deleted men might also suffer a small fitness penalty, expediting the loss of the deleted allele .
Clinical management of globozoospermic patients and DPY19L2: what's new?
The relationship between sperm chromosomal abnormalities and sperm morphology has been widely explored. A link has been clearly established in particular for certain types of morphologically abnormal spermatozoa, such as large-headed multiflagellar spermatozoa, but remains controversial for many others (Sun et al., 2006) . Globozoospermia is no exception and contradictory results were obtained. Some studies report an increased frequency in sperm aneuploidy compared with normal sperm cells while others do not observe any difference (reviewed in Dam et al., 2007a; Perrin et al., 2013) . Finally, even observed, the slightly increased aneuploidy rate in round-headed sperm is comparable to that commonly found in other types of infertility (Perrin et al., 2013) and therefore does not counter indicate the treatment of patients by ICSI (Kuentz et al., 2013) . Despite this, many studies using ICSI for patients with globozoospermia reported low fertilization, pregnancy and live birth rates, overall estimated at 38, 20 and 14%, respectively (reviewed in Dávila Garza and Patrizio, 2013) . A first well-established explanation for the low efficiency of ICSI when using globozoospermic sperm is the reduction or absence of the sperm factor, a testis-specific phospholipase (phospholipase C zeta (PLCz)) involved in the oocyte activation (Yoon et al., 2008; Heytens et al., 2009; Kashir et al., 2010; Amdani et al., 2013; Escoffier et al., 2015) . PLCz localizes to the inner acrosomal membrane and the nuclear theca in the post-acrosomal region of human sperm which is in accordance with its vanishing in Dpy19l2-KO globozoospermic sperm (Escoffier et al., 2015) . The absence of oocyte activation can be overcome by artificial oocyte activation (AOA) using Ca 2+ ionophore (Rybouchkin et al., 1997; Tejera et al., 2008; Kyono et al., 2009; Taylor et al., 2010) . In case of globozoospermia, AOA combined with ICSI improved the efficiency of fertilization, pregnancy and live birth rates compared with conventional ICSI and this, regardless of the genotype (DPY19L2 related or not) of the patients (Kuentz et al., 2013) . However, the live birth rate per transfer remains lower in globozoospermic patients than in other infertile patients in the same age group (Palermo et al., 2009; Kuentz et al., 2013) . This may be due to sperm DNA damage related to defective chromatin condensation and the DNA fragmentation described in globozoospermic sperm cells (Dam et al., 2007a; Brahem et al., 2011; Perrin et al., 2013; Yassine et al., 2015a) . Abnormal chromatin condensation in globozoospermia could be linked to an altered replacement of histones by protamines (Blanchard et al., 1990; Carrell et al., 1999) . Yassine et al. (2015a) using the dpy19l2 KO mouse models confirmed that the nuclear invasion by protamines during the last stage of compaction is defective. Moreover, the absence of protamine increases dramatically the susceptibility to DNA breaks. Altogether, epigenetics defects and DNA fragmentation in globozoospermic sperm nuclei impair the developmental potential of embryos generated by ICSI using Dpy19l2-dependent spermatozoa (Yassine et al., 2015a) . In summary, globozoospermic patients with DPY19L2 gene alterations combine a low oocyte activation rate and a poor development of embryos generated by ICSI, thus explaining the consistently disappointingly low pregnancy rate obtained with these patients. Mutational status in globozoospermic patients treated with ICSI was generally unknown or not investigated. Few studies reported successful fertilization or pregnancies in globozoospermic patients with well documented DPY19L2 or SPATA16 mutations (Dam et al., 2007b; Harbuz et al., 2011; Kuentz et al., 2013; Karaca et al., 2014) . Due to this small number of cases, no evidence of a difference in pregnancy success rate regarding the mutational status of globozoospermic patients has currently been demonstrated. Further studies taking into account genetic mutations may influence the therapeutic strategy and facilitate improving the management of patients diagnosed with globozoospermia. To date, only the type of globozoospermia is known to have an impact on the therapeutic approach as intracytoplasmic morphologically selected sperm injection technique (IMSI) has proven effective only for patients with a partial globozoospermia (Sermondade et al., 2011; Kuentz et al., 2013) .
Multiple morphological abnormalities of the flagella
Morphological abnormalities of the sperm flagella leading to asthenozoospermia have been reported regularly since 1984 (Escalier and David, 1984) . Chemes and colleagues carried out much of the early work on this phenotype and extensively studied the ultrastructure of the sperm flagella of affected men (Chemes et al., 1987) . They observed recurrent abnormalities of the fibrous sheath (FS) which defines the principal piece surrounding the axoneme and the outer dense fibers and consists of two longitudinal columns connected by circumferential ribs (Fig. 4) . Escalier had previously identified similar flagellar defects and had described that abnormalities of the peri-axonemal structures (including FS, outer dense fibers, mitochondrial sheath) were always associated with axonemal defects (Escalier and David, 1984) . She argued that these peri-axonemal defects might be secondary to the axonemal defects (Escalier and Serres, 1985) . Further ultrastructural studies among patients with sperm flagella abnormalities showed a wide range of different peri-axonemal and axonemal defects (Rawe et al., 2001; Chemes and Rawe, 2003) .
Cilia and flagellum: a common origin
Although the sperm flagellum and motile cilia (found in the epithelial cells of the airways, the Fallopian tubes, the choroid plexus and the brain ventricles) are specialized for a particular function, they share common structural elements as the central cytoskeletal structure called the axoneme, which is highly conserved throughout evolution. The axoneme contains 9 outer microtubules doublets and 2 central singlets (9+2 structure), several axonemal dyneins, radial spokes, nexin links and many other components that drive and regulate ciliary or flagellar motility. All these microtubule-associated proteins are attached along the axoneme in a regular 96 nm long repeated formation (Inaba, 2003; Satir and Christensen, 2008) . The axonemal dyneins are multicomponent proteins organized along each microtubule doublet as inner and outer rows ( Fig. 4B and C ) and comprise motor multiprotein complexes which produce the cilia/flagella beating force (Wickstead and Gull, 2007 (Bisgrove and Yost, 2006) . The structure of the inner dynein arms is more complex than the structure of the outer dynein arms, which, in mammals, contains only two different HCs repeated all along the axoneme. In mammals, the inner arms are organized in seven molecular complexes, viewed in electronic microscopy as globular heads arranged in 3-2-2 groups, thus corresponding to 3 types of inner dynein arms (IDA): IDA1 to IDA3 (Vernon et al., 2005) . The mammalian organization was however much less investigated than in Chlamydomonas (Bui et al., 2008) , and the subunit composition of each inner arm remains to be determined. Although sperm flagella and motile cilia have a similar microtubule structure based on the presence of a 9+2 axoneme, they present several differences. Motile cilia are constituted almost exclusively by the axoneme, whereas mammalian sperm flagella are divided into three principal parts characterized by the presence of additional accessory structures surrounding the axoneme: the outer dense fiber, the mitochondrial sheath, the fibrous sheath (Fig. 4) . Recent proteomic analysis identified over 700 proteins that are exclusively localized in the human sperm flagella, of which many are axonemal proteins (Baker et al., 2013) . These data highlight the complexity of the flagella structure and biogenesis, suggesting that many genes could be linked to flagellar abnormalities and/or asthenozoospermia.
Primary ciliary dyskinesia
Primary ciliary dyskinesia (PCD) is a multisystemic disorder caused by motility defects of motile cilia and flagella (Afzelius and Eliasson, 1983; Munro et al., 1994) . PCD is mainly characterized by recurrent respiratory tract infections with varying symptoms ranging from chronic rhinosinusitis to bronchiectasis and male infertility due to sperm immotility (Ibañez-Tallon et al., 2003) . Female subfertility is less common and is caused by dysmotile Fallopian tubes cilia (Lyons et al., 2006) . PCD is also associated in 50% of cases with situs invertus due to dysfunction of motile embryonic node cilia perturbing organ laterality (Zariwala et al., 1993) . More rarely, hydrocephalus arises as a consequence of ependymal cilia dysmotility leading to a blockage of the cerebrospinal fluid flow (Ibañez-Tallon et al., 2002; Kosaki et al., 2004) . PCD has an estimated incidence of 1 per 15 000 births (Knowles et al., 2013a) but it may be underestimated due to diagnostic failure (Boon et al., 2013) .
A high prevalence of PCD was observed in different genetic isolates and consanguineous populations, a fact consistent with a mainly autosomal recessive mode of inheritance (Jeganathan et al., 2004; O'Callaghan et al., 2010) . PCD is genetically heterogeneous (Horani et al., 2014) and research on PCD allowed the characterization of numerous proteins necessary for adequate axonemal molecular structure and assembly. Cilia and flagella are remarkably well conserved throughout evolution. Different experimental models were used to decipher the molecular composition and function of these organelles (Ostrowski et al., 2011) . The first model was the green alga Chlamydomonas in which DNAI1, the first gene to be associated with PCD, was identified (Pennarun et al., 1999) . The function of the genes involved in PCD was also efficiently assessed in other multicellular organisms, such as zebrafish, Xenopus, Caenorhabditis elegans or Drosophila, and protists, such as Paramecium, Tetrahymena, Trypanosoma or Leishmania, each bringing specific advantages to the study of cilium biology (review in Vincensini et al., 2011) . Thereafter, various studies using a candidate gene approach mainly based on data from Chlamydomonas have resulted in the identification of many mutated genes in PCD patients. Different KO mice or inbred dogs deficient in various axonemal components have also been successfully described as mammalian models for PCD (review in Inaba, 2011) . Mutations in 28 genes leading to various ultrastructural defects have so far been described to cause PCD (Table VI) and account for the genetic etiology of 70% of affected individuals . A male infertility phenotype has often been described as part of the clinical symptoms but this particular aspect of the physiopathology of the PCD is not systematically explored and is often only scarcely described in scientific reports (Table VI) . The sperm of infertile male patients with PCD are usually immotile and present various ultrastructural defects of sperm flagella such as missing dynein arms, microtubular translocations, and lack of radial spokes. Nevertheless, in most cases the sperm flagellum appears morphologically normal under direct light microscopy (Table VI) thereby excluding most of these genes as a genetic cause of teratozoospermia or MMAF.
Genetic investigations of MMAF
A genetic origin of MMAF was strongly suspected based on a family clustering reported in at least 20% of patients (Chemes and Alvarez Sedo, 2012) . In 2005, Bacetti et al. (Baccetti et al., 2005a) first reported a partial deletion in the A kinase (PRKA) anchor protein 3 (AKAP3) and A kinase (PRKA) anchor protein 4 (AKAP4) genes in a patient presenting with short-tail spermatozoa. Ultrastructural sperm evaluation showed MMAF and an altered axonemal structure lacking dynein arms and microtubular doublets including the central pair. A kinase (PRKA) anchor protein 3 (AKAP3) and A kinase (PRKA) anchor protein 3 (AKAP4) encode two A-kinase anchoring proteins interacting with the regulatory subunits of cAMP-dependent protein kinase A. AKAP3 and AKAP4 are the most abundant structural proteins of the fibrous sheath. AKAP3 is involved in organizing the basic structure of the fibrous sheath while AKAP4 has a major role in completing fibrous sheath assembly (Brown et al., 2003) . Akap4 KO mice are infertile with half-length flagella with a Moore et al. (2013) and Zariwala et al. (2013) Genetic causes of teratozoospermia thinner principal piece and a tip sometimes curled or splayed into fine filaments. The size and integrity of mutant mitochondrial sheaths are also reduced. However, other cytoskeletal structures, namely the outer dense fibers and the axoneme, remain intact (Miki et al., 2002) . Mouse models thus present strong evidence that Akap3 and 4 are involved in MMAF phenotype. Evidence of their implication in the human phenotype is however weaker. A deletion of AKAP3 and AKAP4 was described in a MMAF patient but it was only detected using conventional PCR and the genomic breakpoints were not identified (Baccetti et al., 2005a) . Moreover, no quantitative analyses of DNA or mRNA were used to confirm the observed deletions and exclude a false negative PCR result. The authors then demonstrated an absence of staining in patient's spermatozoa using immunofluorescence with AKAP4 antibodies (Baccetti et al., 2005a) . The absence of the AKAP4 protein in mature sperm may however be secondary to another defect disorganizing the whole sperm flagella structure (Baccetti et al., 2004) . Additionally, Turner et al. (2001) did not find any mutation in these two genes in 9 MMAF patients.
More recently homozygous mutations in the DNAH1 gene were identified in several patients with MMAF (Ben Khelifa et al., 2014) . DNAH1 encodes an axonemal inner arm dynein HC and is expressed in various tissues including the testis (Maiti et al., 2000) . Homozygosity mapping was carried out on a cohort of 20 North African individuals. Four different homozygous mutations in DNAH1, one run-on, one missense and two splice site mutations were identified in seven patients including three brothers. Electron microscopy examination of spermatozoa revealed a general axonemal disorganization including mislocalization of the microtubule doublets, absence of the central pair in about half of the analyzed cross sections, loss of the inner arm dynein as well as severe disorganization of the fibrous sheath, the outer dense fibers and the mitochondrial sheath (Ben Khelifa et al., 2014) . All these defects are hallmarks of the MMAF phenotype. Molecular and functional studies on samples from one of the mutated patients carrying the recurrent splicing mutation (c.11788-1G.A) demonstrated that the transcript and the protein were absent, confirming that the observed phenotype is due to the complete absence of DNAH1. This initial study thus indicates that 70% of DFS patients are expected to bear a genetic alteration in other genes, thus confirming that, like PCD, MMAF is genetically heterogeneous and that many other genes are likely involved in this syndrome. Lastly, the patient with the less severe missense variant presented a milder phenotype with 5% motility and the presence of 6% morphologically normal spermatozoa in contrast to the other DNAH1-mutated patients which had 100% abnormal sperm and 0% motility (Ben Khelifa et al., 2014) . It could therefore be expected that individuals with intermediate asthenozoospermia and a low level of morphological anomalies could also harbor homozygous or compound heterozygous DNAH1 mutations of moderate severity.
The phenotype observed in DNAH1-mutated patients extends beyond the absence of flagellar motility, as usually observed in other axonemal component defects, and substantiates a role for this protein in the maintenance of the structural integrity of the flagella. In Dnahc1 KO mice (the mouse ortholog of DNAH1, previously called Mdhc7), 'rapid-freeze deep-etch electron microscopy' studies indicated that one head of the IDA3 was missing, leading to a 3-2-1 globular head arrangement and suggesting that DNAH1 is one of the components of the IDA3 (Vernon et al., 2005) . In Tetrahymena thermophila, IDA3 corresponds to the dynein d/a which is directly connected to the radial spoke RS3 through an arc-like structure (King, 2013) . In mammals, the three radial spokes (RS1, RS2, and RS3) are multiprotein complexes allowing a connection between the external microtubule doublets and the two central microtubules thus stabilizing the axoneme (Pigino et al., 2011) . Therefore, the severe axonemal disorganization observed in DNAH1-mutated patients may occur as a result of the abrogation of RS3 anchoring, leading to the absence of the central pair and the mislocalization of the peripheral doublets (Ben Khelifa et al., 2014) . KO male mice lacking Dnah1 are infertile but only present with asthenozoospermia, without the sperm morphological abnormalities observed in human. Aside from the fact that there might be some divergences in flagellar biogenesis between mouse and human, an incomplete disruption of the targeted dynein was reported in the mouse model, which may explain this phenotypic difference (Neesen et al., 2001; Ben Khelifa et al., 2014) .
The central pair microtubules: the central key of MMAF phenotype?
The central pair microtubules (CP) are composed of two microtubule singlets, named C1 and C2, which are structurally and biochemically distinct. Structural studies in Chlamydomonas showed that the C1 tubule has two long projections (1a and 1b) and two short projections (1c and 1d). The C2 tubule has three short projections termed 2a, 2b and 2c. The CP contains at least 23 distinct proteins and some of these proteins are uniquely associated with either C1 or C2, indicating that the two microtubules may be functionally specialized. Evidence supports the fact that the CP projections interact with the RS heads and modulate dynein activity (reviewed in Wargo and Smith, 2003) .
It is worth noting that the lack of the CPs leading to an abnormal '9+0' configuration of the axoneme is the main defect observed in most cases associated with MMAF (Chemes and Rawe, 2003) . Such a defect was also observed in patients with DNAH1 mutations (Ben Khelifa et al., 2014) . These observations raise the hypothesis that CP disorganization might be the cornerstone leading to the MMAF phenotype. Several experimental models support the idea that some structural defects impacting the CP give rise to MMAF (Fig. 4C and Table VII ). Axonemal abnormalities have been observed in spermatids from testicular biopsies underlining that the onset of the defect occurs during the late stages of spermiogenesis due to a defective assembly of cytoskeletal components of the sperm tail (Chemes and Rawe, 2010) . Interestingly, in some cases, the disorganization of the microtubules has been described to increase and the sperm phenotype to worsen during the sperm transit through the epididymal duct (Sapiro et al., 2002; Sironen et al., 2011) . This suggests that CP defects precede other more severe structural abnormalities by weakening all the axonemal organization making the flagella vulnerable to mechanical stress during spermiogenesis and sperm transit. This demonstrates that CP plays a major role in maintaining the global flagellum organization throughout spermiogenesis. This could explain why most other axonemal defects, not affecting the CP structure, do not lead to the MMAF phenotype.
As a consequence, all genes encoding a protein interacting directly (CP components) or indirectly with the CP apparatus, like RS, some dynein arms or different partner proteins, are henceforth good candidates for the MMAF phenotype (Fig. 4C) . As an example, depletion of mouse Meig1, a protein that interacts directly with Spag16 (Table VII) 2010; Teves et al., 2013) . In humans, several studies reported mutations in the coiled-coil domain containing 39 (CCDC39), coiled-coil domain containing 40 (CCDC40), radial spoke head 1 homolog (RSPH1), radial spoke head 4 homolog A (RSPH4A), radial spoke head 9 homolog RSPH9 and HYDIN, axonemal central pair apparatus protein (HYDIN) genes leading to CP defects. However, few phenotypic descriptions or structural studies have been carried out on sperm samples from mutated patients (Table VI) . Only Merveille et al. (2011) reported that the sperm flagellum was shortened in patients with a mutation in the CCDC39 gene, a feature consistent with the MMAF phenotype and our hypothesis.
PCD to MMAF phenotype: a phenotypic continuum?
DNAH1 is the first inner arm dynein gene involved in a human pathology and the first axonemal gene responsible for a male infertility phenotype without any of the other symptoms usually observed in PCD. These novel mutations in the axonemal dynein DNAH1 strengthen the emerging point of view that MMAF may be a phenotypic variation of the classical forms of PCD with a continuum of clinical manifestations ranging from infertile PCD patients to MMAF patients with no or low noise PCD manifestations. Indeed, many genes are likely to have a specific function in the sperm flagellum with potentially several paralogs that could carry out a similar function in other ciliated tissues, thus explaining the absence of a more severe PCD phenotype. For instance, absence of respiratory symptoms in DNAH1-mutated patients may be explained by other dyneins phylogenetically close to DNAH1 which may compensate the absence of DNAH1 in other motile cilia (Ben Khelifa et al., 2014) . This hypothesis has also been mentioned in a reverse situation where PCD patients with mutations in the CCDC114, a gene encoding an outer dynein arm docking complex, had no fertility problems. The authors proposed that CCDC114 function could be partially replaced by CCDC63, a homologous protein of CCDC114 with an expression restricted to the testis . Unfortunately, no nasal brushings or biopsies from DNAH1-mutated individuals could be obtained to search for infra-clinical manifestations by exploring the patient's ciliary function in respiratory epithelium. In addition, alternative splicing is widespread in mammals and splice variants often exhibit tissue-specific expression patterns (Yu et al., 2014) . Therefore some mutations may affect alternative variants specifically expressed in testis while having no effect in other tissues. Overall, these observations support the fact that important differences exist between the axonemal assembly/function of respiratory cilia and sperm flagella that explain why PCDs are not always associated with primary flagellar defects and vice versa. This was supported by mutations in DNAH5, an outer dynein arm, which are associated with the absence of outer dynein arms in respiratory cilia while a normal distribution of ODA heavy chain was reported in the sperm flagellum of mutated patients (Fliegauf et al., 2005) . Mutations in DNAH11, another outer dynein arm, although associated with a normal axonemal ultrastructure, led to a PCD phenotype also with normal male fertility (Bartoloni et al., 2002; Schwabe et al., 2008) . In many mouse models with a MMAF-like phenotype, the structural disorder appears to be specific to sperm tail development, because no effects on the architecture of cilia in the respiratory or female reproductive tract have been observed (Pilder et Sapiro et al., 2002; Sironen et al., 2006 Sironen et al., , 2011 Zhang et al., 2006; Lessard et al., 2007; Lee et al., 2008; Salzberg et al., 2010; Nakamura et al., 2013) . Despite this normal axonemal organization, respiratory symptoms or lower tracheal ciliary beat frequency and/or hydrocephalus were described (Sapiro et al., 2002; Lee et al., 2008; Sironen et al., 2011) . These findings highlight the duality of function of various proteins, involved in sperm flagellum biogenesis and in the motility of tracheal and ependymal cilia. Further studies are needed to elucidate the mechanisms underlying differences between cilia and flagella and to decipher the specific proteome of these two closely related organelles.
Clinical implications of flagellar defects: return to base
In dividing cells, the centrioles form the core of the centrosome which is the primary microtubule-organizing center in animal cells and it is involved in numerous functions such as the organization of the mitotic/meiotic spindle (reviewed in Bettencourt-Dias and Glover, 2007) . During flagellum biogenesis, the sperm centrioles migrate to the spermatid periphery and form the basal bodies from which the flagellar axoneme originates (Chemes, 2012) . Centrioles are embedded in a matrix of proteins known as the pericentriolar material that supports motor proteins such as dyneins or kinesins (Schatten and Sun, 2009) . Moreover, during fertilization in human, the sperm centrosome organizes the sperm aster which is essential to unite the sperm and the oocyte pronuclei (Sathananthan et al., 1991) . The sperm centrosome also controls the syngamy and the first mitotic divisions after fertilization (Schatten and Sun, 2009) .
Primary flagellar abnormalities have been associated with an elevated frequency of gonosomal disomies and diploidies (Lewis-Jones et al., 2003; Baccetti et al., 2005b; Rives et al., 2005; Collodel and Moretti, 2006; Ghedir et al., 2014) . In the light of the above, chromosomal abnormalities observed in MMAF patients may be linked to the common components shared between the sperm centrosome and the flagella. Therefore, it could be speculated that defects in some of these centrosome-associated proteins may disturb both flagellum formation and spindle assembly during sperm meiosis, resulting in nondisjunction errors and spermatozoa aneuploidy (Rives et al., 2005) . No chromosomal abnormalities were however detected in one patient with short-tailed spermatozoa (Viville et al., 2000) pointing out that all flagellar defects do not impact the centrosomal function.
Sperm aneuploidy could impede ICSI outcomes in patients with flagellar defects. Nevertheless several studies described the successful application of ICSI to treat male infertility due to MMAF or PCD (for review Chemes and Rawe, 2003, Chemes and Alvarez Sedo, 2012; Dávila Garza and Patrizio, 2013) . The most recent review estimated the mean overall fertilization, pregnancy and live birth rates in MMAF patients at 63, 57 and 43%, respectively (Dávila Garza and Patrizio, 2013) . In PCD patients, this review found fertilization and pregnancy rates ranging from 55 to 65% and from 35 to 45%, respectively, depending with the sperm source (ejaculated or testicular). The overall live birth rate was estimated at 39%.
Interestingly although the results compare favorably with the overall results obtained after ICSI, the rate of ICSI success seems to be influenced by the type of ultrastructural flagellar defects carried by the patients (Mitchell et al., 2006; Fauque et al., 2009) . Mitchell et al. (2006) reported a lower implantation and clinical pregnancy rate in patients without axonemal central structures (i.e. '9+0' axoneme).
Likewise, Fauque et al. (2009) reported a slower kinetics of early embryo cleavage and a lower implantation rate when a central pair of singlet microtubules was missing. These data question the possibility of a link between some specific axonemal structural defects and abnormal embryonic development in human. Since axonemal structures and sperm asters come from the sperm centrosome, it is possible that some of the described cases of fertilization failure and abnormal embryonic development reported in MMAF patients might be caused by defects in centrosomal or pericentrosomal proteins (Sathananthan, 1994; Van Blerkom, 1996; Chemes, 2012) . The use of heterologous ICSI systems (human-bovine, human-rabbit) with sperm from infertile men with MMAF supported this hypothesis, showing a lower rate of sperm aster formation (Rawe et al., 2002; Terada et al., 2004) . Interestingly, IVF experiments in Dnah1 KO mice demonstrated a retarded rate of early embryo development (Neesen et al., 2001) . Unfortunately, in patients with DNAH1 mutations no data relative to ICSI attempts were available (Ben Khelifa et al., 2014) . Lastly, although there has been no report of an abnormal birth from patients with MMAF or PCD, the risk of genetic defects other than infertility linked to the sperm structural defects should be discussed during genetic counseling (Sha et al., 2014) . We believe that genetics data combined with careful analysis using electron microscopy will, in time, permit us to optimize the course of treatment for MMAF patients.
Translation of the genetic information to the clinic: the way forward ART can circumvent infertility, and IVF with ISCI is possible for most patients regardless of the etiology of the defects. Unfortunately the availability of these technologies does not guarantee success and almost half the couples who seek reproductive assistance fail to achieve a pregnancy. The improvement of ART procedures is therefore particularly relevant and this strongly relies on a better understanding of spermatogenesis and of the molecular physiopathology of infertility. This mission involves the identification of genes responsible for male infertility. To date, a very short list of genes was identified which is in sharp contrast with the fact that several hundreds of genes (probably well in excess of a thousand) are estimated to be involved in spermatogenesis and male reproduction. Although genetic causes of human male fertility remain largely unknown, genetics investigations of some specific teratozoospermic phenotypes have yielded fruitful results. The key to success in the identification of infertility genes was largely based on the study of clinically and genetically homogenous phenotypes in small cohorts with consanguineous subjects and large families. This led in particular to the identification of AURKC and DPY19L2 and to the development of diagnoses for both genes, which are now recommended for patients presenting macrozoospermia and globozoospermia, respectively. Additional efforts are needed to identify genes in others syndromes and more generally in all phenotypes of male infertility in which many genes remain to be identified in human. The recent identification of DNAH1 in patients with MMAF is promising although a positive diagnosis is achieved for only 28% of the patients. This indicates that MMAF is genetically heterogeneous and that many other genes are likely involved in this syndrome.
Homozygosity mapping has so far permitted the identification of the three main genes discussed in this review. This strategy can only be successful when studying large families or consanguineous patients presenting with a very homogeneous phenotypes. Due to the great genetic heterogeneity of infertility, this technique has now reached its limits and microarray analyses are now replaced by the fast evolving technology of next generation sequencing. Sequencing of all the coding sequences, or exome sequencing, can now be realized in a few weeks at a cost of 400-1000 E. Whole exome sequencing will be available on the next day (in a few years time) for probably less than that cost. This technical revolution is what was needed to unlock the secrets of male infertility. Exomic/genomic sequencing of large cohorts of patients is now necessary to identify the thousands of mutations involved in infertility and the hundreds of genes necessary to achieve efficient spermatogenesis. The identification of variants in candidate genes will be fast, but long and complex analyses will be necessary to confirm the pathogenic effect of the identified variants and more so to understand the function of the identified proteins. We can be confident that the number of genes and mutations identified in the pathological context of infertility will increase exponentially over the next few years.
The next step will be to exploit these data to the benefit of the patients. Genotype/phenotype correlation will allow us to provide the best advice and care to patients and to answer many questions: is the risk of aneuploidy increased and is it therefore advisable to do ICSI? Or do we recommend performing PGD? Can we expect to find some sperm in this patient's testis and is it worth doing a biopsy? Such prognoses are already available for a handful of patients: ICSI is contraindicated to patients with a homozygous AURKC mutation and a testicular biopsy should not be attempted for men with an AZFa or b deletion (Krausz et al., 2014) . The discovery of DPY19L2 provided a better insight of the molecular pathogeny of globozoospermia. A recent work showed that testicular sperm present similar DNA defects to epididymal sperm thus suggesting that testicular biopsy is not relevant in this case (Yassine et al., 2015a) . Moreover, the demonstration that the sperm factor (PLCzeta) is absent in globozoospermic sperm might justify the use of AOA in this pathology (Escoffier et al., 2015) . With an increased list of genes associated with infertility we can expect that a better prognosis and improved advice and treatments will soon be available to many more patients.
We are also convinced that another revolution is brewing. We are currently measuring the limitation of the whole IVF and ICSI strategy that is proposed to most infertile patients, especially those bearing the most severe defects. Alternative treatment strategies will only be possible with an in-depth comprehension of all aspects of spermatogenesis and of the physiopathology of sperm defects. The basis of this comprehension stems from the identification of the genes involved and of their function. We believe that male infertility might be among the pathologies that are best suited for targeted protein therapy and we are convinced that restoration of a functional spermatogenesis will be possible by reintroducing a deficient or missing protein as: (i) treatment success can be measured easily and objectively by a mere spermogram, (ii) in man spermatogenesis lasts 70 days. This corresponds to the necessary treatment duration to obtain functional gametes, which can then be cryopreserved and used at a later date to initiate any number of pregnancies. This relatively short treatment is in sharp contrast with life-long supplementations needed for most other genetic diseases. We thus believe the identification of the genetic causes of infertility will permit us to develop therapies tailored to restore specifically the identified defects. Different options are possible, ranging from direct protein or mRNA injection into Genetic causes of teratozoospermia the rete testis (Ogawa et al., 1997) to injection of expression vectors via lipid shuttles or a virus vector such as adeno-associated viruses (AAV). As the targeted cells produce the gametes that will be used to achieve a pregnancy it is crucial that no genetic material is inserted into the genome, to preclude the transmission of potential deleterious effects to the next generations. At the moment even AAV vectors, which are considered as non-integrating and have been used successfully on post mitotic tissues in many clinical trials, have been found integrating the genome of the target cells at a frequency of 10 24 -10 25 (Kaufmann et al., 2013) . For the time being, this low level of insertion precludes the utilization of viral vectors in the context of infertility, but we can hope that fully non-integrative vector will soon be available. Protein therapy is also possible ex vivo in testis culture systems but it is labor intensive and therefore less amenable to transposition to many different specific genetic defects. KO mice that have so far been used to study the physiopathology of abnormal spermatogenesis should now be used to evaluate the feasibility of different treatment options. The efficient delivery of the replacement protein will be subordinate to the nature and the localization of the defective native protein and the mode of delivery will have to be adjusted to ensure specificity. We however firmly believe that the restricted localization of the targeted cells (in the testis) and the limited duration of treatment clearly favor the development of innovative therapies applied to male infertility. In conclusion, now is a very exciting time in the field of the genetics of infertility. We have so far seen only a small part of the tip of the iceberg but we are confident that the rest will come to light in the foreseeable future. We believe that this work will be the cornerstone of the next revolution in ART allowing the clinician not just to bypass the abnormalities by forceful ICSI but to propose new therapeutic strategies allowing the selective repair of the broken parts.
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